Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
about
Multifaceted roles of cysteinyl leukotrienes in eliciting eosinophil granule protein secretionSingle Nucleotide Polymorphisms in Cellular Drug Transporters Are Associated with Intolerance to Antiretroviral Therapy in Brazilian HIV-1 Positive IndividualsEosinophil granules function extracellularly as receptor-mediated secretory organellesAn overview of the molecular and epidemiological features of HIV-1 infection in two major cities of Bahia state, Brazil.Phylogeographic analysis of HIV-1 subtype C dissemination in Southern BrazilConcurrent partnerships and HIV: an inconvenient truth.Tracing the origin and northward dissemination dynamics of HIV-1 subtype C in BrazilDrug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in MoroccoThe Evolving Genotypic Profile of HIV-1 Mutations Related to Antiretroviral Treatment in the North Region of Brazil.HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil.Differential secretion of cytokines.Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008)Distribution of human immunodeficiency virus type 1 subtypes in the State of Amazonas, Brazil, and subtype C identification.A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality.Autochthonous horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil.The challenge of antiretroviral drug resistance in HIV-1-infected children.Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.Human immunodeficiency virus type-1 subtypes of infected patients in Espírito Santo, Brazil.Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.HIV genotyping among female sex workers in the State of Santa Catarina.HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection.Cross-Talk between Macrophage Migration Inhibitory Factor and Eotaxin in Allergic Eosinophil Activation Forms Leukotriene C4–Synthesizing Lipid BodiesPrevalence of antiretroviral drug resistance among treatment-naive and treated HIV-infected patients in Venezuela.
P2860
Q28260328-EE05E101-F08E-49CF-8D06-8D917D09EEFFQ28554250-CFB91E1D-9F03-49DE-9B68-433E0DB23FE5Q30484748-5B13FE5E-DC80-46B5-827C-3B8E8FF20424Q33732319-263F8F86-A086-441A-871B-E05471DD5C44Q34243959-FFED0CD0-6A35-4786-AD4F-1271720A2FAEQ34722497-17F62232-6CAB-4409-9B93-0CC12080299DQ34998985-CDB558AB-5CE1-4C60-B62C-4DF9983FB535Q36102579-4ED2BD37-635E-4F54-BD79-EBC485BC528CQ36205277-20F68B83-8832-4DA9-846F-092BDA3B9F3CQ36310682-C3154A85-FCD4-455D-95EF-5BEE067950B6Q36498889-6A938EF7-56AE-4024-8F7F-B06BCD9794A2Q37268341-ACBBA405-A774-4540-A0CA-C409E5CD6979Q37371080-6B1E8FB1-D400-4B5C-A6D6-10228B881C29Q39743833-7CCBAC7A-8A19-4688-9671-9768F249CD98Q39820666-924E4BED-53ED-4555-B4C7-B2E68E159918Q42593697-38364278-662C-4AA3-92D5-D9FB3451E8E6Q43463418-AFFFBC2A-25A7-40F8-8B3B-4EFA749D626FQ45362328-3F81C857-A85B-4D11-A4E5-F8DA03B4B1C1Q45407359-EF2E03FC-BE06-4422-95DA-E01C11612400Q45408530-7D151E9B-F7AE-4BA8-AEA5-D1B0F7C0A5F1Q51744910-628A92ED-4AE0-4176-B962-E92DFC4C1682Q55020251-CEC8A456-19D1-4DBD-BF37-47F50129C284Q56798090-35C1FED1-6AA0-4FB4-99BD-EC457AEF8447Q57574707-5295E6E1-581A-4539-A800-8B54A8B09713
P2860
Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Human immunodeficiency virus t ...... active antiretroviral therapy.
@en
Human immunodeficiency virus t ...... active antiretroviral therapy.
@nl
type
label
Human immunodeficiency virus t ...... active antiretroviral therapy.
@en
Human immunodeficiency virus t ...... active antiretroviral therapy.
@nl
prefLabel
Human immunodeficiency virus t ...... active antiretroviral therapy.
@en
Human immunodeficiency virus t ...... active antiretroviral therapy.
@nl
P2093
P2860
P1476
Human immunodeficiency virus t ...... active antiretroviral therapy.
@en
P2093
Arakaki-Sanchez D
Chequer PJ
Chequer-Fernandez SL
Couto-Fernandez JC
Morgado MG
Oliveira SM
Silva-de-Jesus C
P2860
P356
10.1590/S0074-02762005000100014
P577
2005-02-01T00:00:00Z